2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole

C136H121N25 — CID 158388231

IUPAC2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole
SMILESCc1ccc(-c2cn(C)c(CCc3ccc4ncccc4n3)n2)cn1.Cc1ccc(C)c2nc(CCC3=Nc4c(ccc5ncccc45)C3)ccc12.Cc1ccnc2ccc(CCc3nc4c5ccccc5ccc4n3C)nc12.Cc1ncc(C)c2nc(CCc3nc4c5ccccc5ccc4n3C)ccc12.Cc1ncc(C)c2nc(CCc3nc4c5ncccc5ccc4n3C)ccc12.Cn1c(CCc2ccc3cccnc3n2)nc2c3ccccc3ccc21
InChIInChI=1S/C24H22N4.C24H21N3.C23H21N5.C23H20N4.C22H18N4.C20H19N5/c1-15-14-25-16(2)19-11-9-18(26-23(15)19)10-13-22-27-24-20-7-5-4-6-17(20)8-12-21(24)28(22)3;1-15-5-6-16(2)23-20(15)11-10-18(26-23)8-9-19-14-17-7-12-22-21(24(17)27-19)4-3-13-25-22;1-14-13-25-15(2)18-9-7-17(26-21(14)18)8-11-20-27-23-19(28(20)3)10-6-16-5-4-12-24-22(16)23;1-15-13-14-24-19-10-8-17(25-22(15)19)9-12-21-26-23-18-6-4-3-5-16(18)7-11-20(23)27(21)2;1-26-19-12-9-15-5-2-3-7-18(15)21(19)25-20(26)13-11-17-10-8-16-6-4-14-23-22(16)24-17;1-14-5-6-15(12-22-14)19-13-25(2)20(24-19)10-8-16-7-9-17-18(23-16)4-3-11-21-17/h4-9,11-12,14H,10,13H2,1-3H3;3-7,10-13H,8-9,14H2,1-2H3;4-7,9-10,12-13H,8,11H2,1-3H3;3-8,10-11,13-14H,9,12H2,1-2H3;2-10,12,14H,11,13H2,1H3;3-7,9,11-13H,8,10H2,1-2H3
InChIKeyGWPVLWNDGOQPBU-UHFFFAOYSA-N
MW2105.64 g/mol
LogP27.94
Rot. Bonds19

About 2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole

2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole (PubChem CID 158388231) has the molecular formula C136H121N25 and a molecular weight of 2105.64 g/mol. Its IUPAC name is 2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole.

Molecular Properties

Compound Name2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole
PubChem CID158388231
Molecular FormulaC136H121N25
Molecular Weight2105.64 g/mol
Exact Mass2104.02
IUPAC Name2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole
SMILESCc1ccc(-c2cn(C)c(CCc3ccc4ncccc4n3)n2)cn1.Cc1ccc(C)c2nc(CCC3=Nc4c(ccc5ncccc45)C3)ccc12.Cc1ccnc2ccc(CCc3nc4c5ccccc5ccc4n3C)nc12.Cc1ncc(C)c2nc(CCc3nc4c5ccccc5ccc4n3C)ccc12.Cc1ncc(C)c2nc(CCc3nc4c5ncccc5ccc4n3C)ccc12.Cn1c(CCc2ccc3cccnc3n2)nc2c3ccccc3ccc21
InChIInChI=1S/C24H22N4.C24H21N3.C23H21N5.C23H20N4.C22H18N4.C20H19N5/c1-15-14-25-16(2)19-11-9-18(26-23(15)19)10-13-22-27-24-20-7-5-4-6-17(20)8-12-21(24)28(22)3;1-15-5-6-16(2)23-20(15)11-10-18(26-23)8-9-19-14-17-7-12-22-21(24(17)27-19)4-3-13-25-22;1-14-13-25-15(2)18-9-7-17(26-21(14)18)8-11-20-27-23-19(28(20)3)10-6-16-5-4-12-24-22(16)23;1-15-13-14-24-19-10-8-17(25-22(15)19)9-12-21-26-23-18-6-4-3-5-16(18)7-11-20(23)27(21)2;1-26-19-12-9-15-5-2-3-7-18(15)21(19)25-20(26)13-11-17-10-8-16-6-4-14-23-22(16)24-17;1-14-5-6-15(12-22-14)19-13-25(2)20(24-19)10-8-16-7-9-17-18(23-16)4-3-11-21-17/h4-9,11-12,14H,10,13H2,1-3H3;3-7,10-13H,8-9,14H2,1-2H3;4-7,9-10,12-13H,8,11H2,1-3H3;3-8,10-11,13-14H,9,12H2,1-2H3;2-10,12,14H,11,13H2,1H3;3-7,9,11-13H,8,10H2,1-2H3
InChIKeyGWPVLWNDGOQPBU-UHFFFAOYSA-N
XLogP27.94
TPSA281.92 Ų
H-Bond Donors
H-Bond Acceptors25
Rotatable Bonds19
Heavy Atoms161
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002105.64
LogP ≤ 527.94
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1025

Analyze 2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole?
The IUPAC name of 2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole (CID 158388231) is 2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole.
What is the SMILES notation for 2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole?
The canonical SMILES for 2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole is Cc1ccc(-c2cn(C)c(CCc3ccc4ncccc4n3)n2)cn1.Cc1ccc(C)c2nc(CCC3=Nc4c(ccc5ncccc45)C3)ccc12.Cc1ccnc2ccc(CCc3nc4c5ccccc5ccc4n3C)nc12.Cc1ncc(C)c2nc(CCc3nc4c5ccccc5ccc4n3C)ccc12.Cc1ncc(C)c2nc(CCc3nc4c5ncccc5ccc4n3C)ccc12.Cn1c(CCc2ccc3cccnc3n2)nc2c3ccccc3ccc21.
What is the InChIKey of 2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole?
The InChIKey is GWPVLWNDGOQPBU-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H22N4.C24H21N3.C23H21N5.C23H20N4.C22H18N4.C20H19N5/c1-15-14-25-16(2)19-11-9-18(26-23(15)19)10-13-22-27-24-20-7-5-4-6-17(20)8-12-21(24)28(22)3;1-15-5-6-16(2)23-20(15)11-10-18(26-23)8-9-19-14-17-7-12-22-21(24(17)27-19)4-3-13-25-22;1-14-13-25-15(2)18-9-7-17(26-21(14)18)8-11-20-27-23-19(28(20)3)10-6-16-5-4-12-24-22(16)23;1-15-13-14-24-19-10-8-17(25-22(15)19)9-12-21-26-23-18-6-4-3-5-16(18)7-11-20(23)27(21)2;1-26-19-12-9-15-5-2-3-7-18(15)21(19)25-20(26)13-11-17-10-8-16-6-4-14-23-22(16)24-17;1-14-5-6-15(12-22-14)19-13-25(2)20(24-19)10-8-16-7-9-17-18(23-16)4-3-11-21-17/h4-9,11-12,14H,10,13H2,1-3H3;3-7,10-13H,8-9,14H2,1-2H3;4-7,9-10,12-13H,8,11H2,1-3H3;3-8,10-11,13-14H,9,12H2,1-2H3;2-10,12,14H,11,13H2,1H3;3-7,9,11-13H,8,10H2,1-2H3.
What are the key properties of 2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole?
2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole has a molecular weight of 2105.64 g/mol, XLogP of 27.94, 19 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylbenzo[e]benzimidazole;2-[2-(5,8-dimethyl-1,6-naphthyridin-2-yl)ethyl]-3-methylimidazo[4,5-h]quinoline;2-[2-(5,8-dimethylquinolin-2-yl)ethyl]-3H-pyrrolo[2,3-f]quinoline;3-methyl-2-[2-(8-methyl-1,5-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole;2-[2-[1-methyl-4-(6-methyl-3-pyridinyl)imidazol-2-yl]ethyl]-1,5-naphthyridine;3-methyl-2-[2-(1,8-naphthyridin-2-yl)ethyl]benzo[e]benzimidazole is sourced from PubChem (CID 158388231), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).